Wikidata

(Q66045450)

English

A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

short name
CheckMate 648 (English)
0 references
title
A Randomized Phase 3 Study of Nivolumab Plus Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin in Subjects With Unresectable Advanced, Recurrent or Metastatic Previously Untreated Esophageal Squamous Cell Carcinoma (English)
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Brazil
0 references
Canada
0 references
Chile
0 references
Colombia
0 references
Denmark
0 references
France
0 references
Italy
0 references
Japan
0 references
Mexico
0 references
Peru
0 references
Poland
0 references
Portugal
0 references
Romania
0 references
Singapore
0 references
Spain
0 references
Taiwan
0 references
Turkey
0 references
United Kingdom
0 references
start time
19 June 2017
0 references
end time
25 May 2020
0 references
number of participants
939
0 references
research intervention
cisplatin
0 references
fluorouracil
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q66045450&oldid=2238249931"